Page last updated: 2024-09-03
rc 3095 and dizocilpine maleate
rc 3095 has been researched along with dizocilpine maleate in 1 studies
Compound Research Comparison
Studies (rc 3095) | Trials (rc 3095) | Recent Studies (post-2010) (rc 3095) | Studies (dizocilpine maleate) | Trials (dizocilpine maleate) | Recent Studies (post-2010) (dizocilpine maleate) |
---|---|---|---|---|---|
108 | 2 | 26 | 7,741 | 9 | 1,449 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Henriques, JA; Meller, CA; Roesler, R; Schwartsmann, G | 1 |
Other Studies
1 other study(ies) available for rc 3095 and dizocilpine maleate
Article | Year |
---|---|
The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice.
Topics: Animals; Antineoplastic Agents; Apomorphine; Bombesin; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Mice; Peptide Fragments; Receptors, Bombesin; Schizophrenia | 2004 |